The international organ allocation organization Eurotransplant has introduced on April 24 within eight European countries the virtual crossmatch for allocation of kidney and pancreas transplants. The Eurotransplant Reference Laboratory (ETRL), housed in the Department of Immunology of the LUMC and headed by dr. Sebastiaan Heidt, has played a pivotal role in the implementation of the virtual crossmatch.
Ramon Arens and his group have discovered biomarkers that may predict whether a patient responds to immunotherapy. In this way, the treatment plan can be evaluated in time and per patient with cancer and possibly adjusted.
Looking for information on one of our topics, a new place to conduct your research or connect to experienced researchers to join forces with? Feel free to contact us!